Pancreatic Cancer Research

ResearcherWashington University in St. LouisNo recent work listed

Hongmei Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5117-5212; OpenAlex author ID A5030541475. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2017: 1 paper · 2018: 2 papers · 2019: none · 2020: 1 paper

Papers 4

  1. Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion. Co-author DOI 10.1136/gutjnl-2018-317424↗
  2. Tumor-Stroma IL1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-17-1366↗
  3. Concurrent HER or PI3K Inhibition Potentiates the Antitumor Effect of the ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models. Co-author DOI 10.1158/1535-7163.mct-17-1142↗
  4. Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-16-1121↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kian‐Huat Lim · 4 shared papers, 2017–2020 · strength 0.34
  2. Daoxiang Zhang · 3 shared papers, 2017–2018 · strength 0.23
  3. Andrea Wang‐Gillam · 3 shared papers, 2017–2018 · strength 0.23
  4. David G DeNardo · 2 shared papers, 2017–2020 · strength 0.18
  5. Samarth Hegde · 1 shared paper, 2020 · strength 0.11
  6. Hong Jiang · 1 shared paper, 2020 · strength 0.11
  7. Ryan C Fields · 1 shared paper, 2020 · strength 0.11
  8. Patrick M. Grierson · 1 shared paper, 2018 · strength 0.08
  9. Qiong Li · 1 shared paper, 2018 · strength 0.08
  10. Paarth B. Dodhiawala · 1 shared paper, 2018 · strength 0.08
  11. Albert Craig Lockhart · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.